Valens Company Inc., a leading producer of cannabis products, announces that it has entered into a manufacturing partnership with Montreal Cannabis Médical Inc. to handle the manufacturing and extraction of MTL’s pre-rolls and vapes.
Valens expects the contract to begin at the end of the first quarter of fiscal 2022.
MTL is a flower-first company dedicated to bringing artisan cannabis to the masses through a five-step process that includes an award-winning hydroponic system, hang-drying, and hand-pruning. With industry-leading yields, MTL offers high-quality cannabis at a competitive price. Since launching to the adult-use market in October 2020, MTL Cannabis has become one of the fastest-growing dried flower consumption brands in Canada, ranking among the top five dried flower providers in most provinces.
“MTL has demonstrated the kind of success, consistency and quality that The Valens Company looks for in a partner,” said Tyler Robson, CEO of The Valens Company. “We are excited to expand our presence with one of the fastest growing and reputable flower consumer brands in Canada.”
“Valens not only has one of the broadest ranges of manufacturing capabilities but also shares the same commitment to consumers and quality that we do,” said Richard Clement, CEO of MTL Cannabis. “We look forward to working with Valens to expand our offering for consumers in a greater variety of formats.”
At Valens, it’s personal.
